3049 companies

Tianda Pharmaceuticals

Market Cap: HK$350.5m

Engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia.

455

HK$0.15

7D

-4.4%

1Y

-35.7%

DongKoo Bio & Pharma

Market Cap: ₩137.9b

Manufactures and sells pharmaceuticals in South Korea.

A006620

₩5,100.00

7D

0%

1Y

-12.2%

Chongqing Lummy Pharmaceutical

Market Cap: CN¥4.8b

Engages in the research and development, manufacture, and sale of pharmaceutical products in China.

300006

CN¥4.53

7D

-2.2%

1Y

63.5%

SillaJen

Market Cap: ₩431.0b

Develops and commercializes oncolytic immunotherapy products in South Korea.

A215600

₩3,170.00

7D

-5.9%

1Y

16.5%

HighTide Therapeutics

Market Cap: HK$2.4b

A clinical-stage biopharmaceutical company, focuses on the development of therapies to treat patients with chronic metabolic and liver diseases in Mainland China.

2511

HK$4.13

7D

22.2%

1Y

353.8%

Sigachi Industries

Market Cap: ₹12.0b

Manufactures and sells microcrystalline cellulose and cellulose powder worldwide.

SIGACHI

₹37.70

7D

20.5%

1Y

-31.9%

UBI Pharma

Market Cap: NT$1.7b

UBI Pharma Inc. develops, manufactures, and sells pharmaceutical products in Taiwan.

6562

NT$14.25

7D

1.8%

1Y

-62.3%

Human Stem Cells Institute

Market Cap: ₽4.3b

Public Joint-Stock Company ‘Human Stem Cells Institute’ operates as a biotech company primarily in Russia.

ISKJ

₽59.54

7D

0%

1Y

-32.9%

Street Capital

Market Cap: CA$1.4m

Focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada.

STRC.X

CA$0.005

7D

0%

1Y

0%

FinCanna Capital

Market Cap: CA$5.0m

Does not have significant operations.

CALI.X

CA$0.005

7D

0%

1Y

n/a

Blueberries Medical

Market Cap: CA$7.4m

Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.

BBM

CA$0.015

7D

0%

1Y

50.0%

Indo-Bangla Pharmaceuticals

Market Cap: ৳1.6b

Engages in the manufacture and sale of various medicines, medical preparations drugs, and chemicals in Bangladesh and internationally.

IBP

৳13.40

7D

-6.3%

1Y

3.9%

HLS Therapeutics

Market Cap: CA$177.4m

A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.

HLS

CA$5.72

7D

5.3%

1Y

70.7%

Enorama Pharma

Market Cap: SEK 178.6m

A pharmaceutical company, develops, manufactures, and sells medicated chewing gum containing proven generic substances in Sweden.

ERMA

SEK 2.66

7D

-1.5%

1Y

-37.9%

Celyad Oncology

Market Cap: €13.8m

A biotechnology company, focuses on the research and development of chimeric antigen receptor T cell (CAR T) therapies for cancer.

CYAD

€0.31

7D

-0.3%

1Y

34.3%

FLUENT

Market Cap: US$38.2m

Through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas.

FNT.U

US$0.06

7D

0%

1Y

-64.7%

Lipum

Market Cap: SEK 307.6m

A biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden.

LIPUM

SEK 14.50

7D

9.4%

1Y

19.8%

Cannabis Poland

Market Cap: zł15.3m

Engages in the retail and wholesale of products based on hemp containing cannabidiol (CBD) in Poland.

CBD

zł0.31

7D

-0.6%

1Y

-29.8%

Salarius Pharmaceuticals

Market Cap: US$2.4m

Operates as a clinical-stage biotechnology company that focuses on developing treatments for cancers with unmet medical need.

SLRX

US$4.58

7D

-4.6%

1Y

-80.9%

Maravai LifeSciences Holdings

Market Cap: US$679.3m

A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.

MRVI

US$2.60

7D

10.2%

1Y

-70.5%

Dextech Medical

Market Cap: €178.4m

Engages in the development of drug candidates with application in urological oncology, primarily prostate cancer.

LQ0

€0.81

7D

7.2%

1Y

110.1%

RedHill Biopharma

Market Cap: US$4.7m

A specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases.

RDHL

US$1.51

7D

18.0%

1Y

-86.1%

Tevogen Bio Holdings

Market Cap: US$174.0m

A clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders.

TVGN

US$0.87

7D

-2.0%

1Y

98.8%

Avacta Group

Market Cap: UK£213.8m

Engages in the development of cancer therapies in the United Kingdom, South Korea, and internationally.

AVCT

UK£0.55

7D

-3.5%

1Y

-23.6%

Foghorn Therapeutics

Market Cap: US$307.0m

A clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States.

FHTX

US$5.15

7D

-2.3%

1Y

-44.4%

Sonnet BioTherapeutics Holdings

Market Cap: US$21.3m

A biotechnology company, owns a platform for biologic medicines of single or bifunctional action.

SONN

US$3.49

7D

11.5%

1Y

-46.5%

Tissue Regenix Group

Market Cap: UK£18.2m

A medical technology company, develops and commercializes platform technologies for bone graft substitutes, skin, and soft tissue biologics markets in the United States and internationally.

TRX

UK£0.26

7D

-12.1%

1Y

-57.1%

Ryvu Therapeutics

Market Cap: zł654.3m

A clinical-stage drug discovery and development company, engages in developing of small molecule therapies for treatment in oncology in Poland, European Union, and internationally.

RVU

zł28.30

7D

1.8%

1Y

-47.6%

Tanvex BioPharma

Market Cap: NT$12.2b

A biopharmaceutical company, researches, develops, manufactures, and sells biosimilar products in Taiwan and the United States.

6541

NT$50.30

7D

-4.2%

1Y

-28.8%

Pressure BioSciences

Market Cap: US$4.3k

Develops and sells high pressure technology-based instruments, consumables, and services for life sciences and other industries worldwide.

PBIO

US$0.0001

7D

0%

1Y

-99.6%

Synthaverse

Market Cap: zł321.3m

A pharmaceutical company, manufactures and sells medicinal preparations, medical devices, and laboratory reagents in Poland, rest of the European Union, and internationally.

SVE

zł4.54

7D

-3.8%

1Y

-1.8%

BioVaxys Technology

Market Cap: CA$8.8m

A clinical-stage biotechnology company, engages in developing viral and oncology vaccine platforms and immuno-diagnostics.

BIOV

CA$0.30

7D

0%

1Y

-50.0%

Huaren Pharmaceutical

Market Cap: CN¥4.0b

Produces and sells non-PVC soft bag infusions in China.

300110

CN¥3.40

7D

2.4%

1Y

11.8%

DT&CRO

Market Cap: ₩40.8b

Operates as a full-service CRO provider in South Korea.

A383930

₩3,140.00

7D

0.6%

1Y

-49.0%

Orthocell

Market Cap: AU$281.5m

A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia and internationally.

OCC

AU$1.11

7D

-2.2%

1Y

138.7%

Taho Pharmaceuticals

Market Cap: NT$10.1b

A pharmaceutical company, develops products using transdermal and transmucosal systems in Taiwan.

6467

NT$181.00

7D

-5.7%

1Y

n/a

Page 63 of 85